Avandia-Rosiglitazone
« Back to Pharmaceutical Litigation
Q: What is Avandia and how is it used?
A: Avandia (rosiglitazone maleate) increases the sensitivity of insulin receptors to improve control of blood sugar levels of diabetes patients. Approved by the FDA in 1999, Avandia can be used in combination with insulin and other medications for patients with type-2 diabetes. Studies have shown that the drug can put patients at risk of developing serious and potentially fatal side effects. In May 2007, the FDA issued a safety alert for Avandia.
Q: Why is Avandia dangerous?
A: Avandia can cause congestive heart failure, heart attack, liver toxicity, severe allergic reaction and stroke.
If you or a loved one has suffered any of the above side effects from the use of Avandia, please, contact us today for a free, no obligation consultation.
Join us on
Follow us on 
RSS Feed 